Investorideas.com | big ideas for the small cap investor- One of the first online investor resources providing research tools for renewable energy, water and Homeland Security Investing Search www.investorideas.com
   Members       Free Stock Alerts       Stock Quotes        Stock Directories       Stock Research       Green Stocks       MicroCap         News        Video       Funding   




InvestorIdeas.com Snapshot for - TSX Top Traders: (KEL), (BTO), (NRI), (BBD-B)

Category: Investment

Ideas get bigger when you share them...

 

Visit: B2Gold Corp.

New York, New York - March 5, 2013 (www.investorideas.com newswire) Kelt Exploration Ltd., (TSX:KEL) trading at $5.620 gained $0.100 or 1.81% on a volume of 3,874,212 shares, making it today's top trader on the TSX.

Kelt Exploration Ltd., (TSX:KEL) trading at $5.620 gained $0.100 or 1.81% on a volume of 3,874,212 shares, making it today's top trader on the TSX.

Investorideas.com Newswire

B2Gold Corp., (TSX:BTO) trading at $2.820 dropped $-0.030 or -1.05% on a volume of 3,245,297 shares.

Investorideas.com Newswire

Nuvo Research Inc., (TSX:NRI) trading at $0.055 lowered by $-0.020 or -26.67% on a volume of 3,037,477 shares.

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Nuvo Research Inc. announced earlier today that its U.S. licensing partner, Mallinckrodt, the Pharmaceuticals Business of Covidien, has received a Complete Response Letter from the U.S. Food and Drug Administration following the review of Mallinckrodt's New Drug Application for diclofenac sodium topical solution, 2% w/w (PENNSAID 2%).

In the letter, the FDA requires that Mallinckrodt successfully complete a pharmacokinetic study comparing PENNSAID 2% to original PENNSAID 1.5%. Similar pharmacokinetic studies submitted by Mallinckrodt with the NDA were not acceptable to the FDA because reserve samples were not retained at the clinical site. Mallinckrodt has indicated to Nuvo that it expects to complete the study and submit the results to the FDA in the third calendar quarter of 2013, and that it anticipates the FDA will provide a formal response to the filing within 6 months thereafter.

Bombardier Inc., (TSX:BBD-B) trading at $4.05 went down $-0.01 or -0.25% on a volume of 3,028,870 shares.

Bombardier announced yesterday that it will provide a program update on its game-changing CSeries aircraft to media representatives and financial analysts at 10 a.m. on March 7 th, 2013, at its facility in Mirabel, Québec. Invitees can attend the two-hour event in person or join via live webcast. UK-based journalists are invited to attend a briefing and tour of Bombardier''s Belfast, Northern Ireland, CSeries wing manufacturing and assembly facility, where they will also be able to join the live video webcast.

Shortly after the event, a recording of the webcast will be available at: www.bombardier.com and www.ir.bombardier.com.

About TSX

http://www.tmx.com/

About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com

Sign up for the free investor news and stock alerts at Investorideas.com

http://www.investorideas.com/Resources/Newsletter.asp

Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…

http://www.investorideas.com/membership/

Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

800-665-0411 - Source - www.Investorideas.com


Free Investor Stock Alerts
Email:  




TOP

Investor Ideas © 2000 - 2013 InvestorIdeas.com®, ECON

Free Investor Stock Alerts
Sign up here

login | logout | about us | contact | disclaimer / disclosure |
advertise | company profile directory | partners / links |
job search | privacy policy | trade | services | sitemap |